Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks t... Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology. 詳細を表示
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that on September 23, 2024, the Board of Directors granted Catherine Owen Adams, Acadia’s new Chief Executive Officer, a one-time...
- Ms. Owen Adams brings over 25 years of pharmaceutical industry experience including senior commercial leadership roles with Bristol Myers Squibb and Johnson & Johnson Acadia...
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate at two upcoming investor conferences: Morgan Stanley 22nd Annual Global Healthcare Conference Fireside Chat:...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.72 | -4.38756855576 | 16.41 | 16.61 | 15.24 | 2224022 | 15.79213991 | CS |
4 | -0.75 | -4.56204379562 | 16.44 | 17.029 | 15.24 | 1298020 | 16.0174952 | CS |
12 | 0.07 | 0.44814340589 | 15.62 | 19.44 | 15.08 | 1765679 | 16.8262513 | CS |
26 | -2.21 | -12.3463687151 | 17.9 | 19.44 | 14.55 | 1684779 | 16.45606075 | CS |
52 | -7.99 | -33.7415540541 | 23.68 | 32.59 | 14.55 | 1779443 | 20.63621267 | CS |
156 | -1.23 | -7.2695035461 | 16.92 | 33.99 | 12.24 | 1689600 | 20.41917134 | CS |
260 | -21.87 | -58.2268370607 | 37.56 | 58.72 | 12.24 | 1625485 | 26.58820016 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約